BHVN
Biohaven Ltd.
$10.07
+$0.62(+6.56%)
30
Overall
40
Value
27
Tech
23
Quality
Market Cap
$892.85M
Volume
2.22M
52W Range
$7.48 - $18.57
Target Price
$19.80
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $567.9M | $436.1M | $885.1M | $745.4M | ||
| Research & Development | $437.1M | $373.3M | $795.9M | $635.1M | ||
| Research Expense | $437.1M | $373.3M | $795.9M | $635.1M | ||
| Selling, General & Administrative | $130.9M | $62.8M | $89.2M | $110.3M | ||
| General & Administrative Expenses | $130.9M | $62.8M | $89.2M | $110.3M | ||
| Salaries & Wages | $193.6M | -- | -- | -- | ||
| Depreciation & Amortization | $1.4M | $3.4M | $3.9M | -- | ||
| Depreciation & Amortization | $1.4M | -- | -- | -- | ||
| Amortization | $1.4M | $1.4M | $1.4M | -- | ||
| OPERATING INCOME | ||||||
| Operating income | $-567.9M | $-436.1M | $-885.1M | $-745.4M | ||
| EBITDA | $-568.5M | $-402.6M | $-837.8M | $-727.5M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Income Operating | $1.5M | -- | -- | -- | ||
| Intinc | $1.8M | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $1.8M | $7.4M | $7.0M | -- | ||
| Gain on Sale of Securities | $3.2M | -- | -- | -- | ||
| Other Income/Expense | $-1.9M | $-26.5M | $-39.4M | $-8.0M | ||
| Other Special Charges | $-1.9M | $26.5M | $39.4M | $8.0M | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-569.8M | $-409.6M | $-845.7M | $-737.4M | ||
| Pre-Tax Income | $-569.8M | $-409.6M | $-845.7M | $-737.4M | ||
| INCOME TAX | ||||||
| Tax Provision | $438.0K | $-1.4M | $735.0K | $1.4M | ||
| NET INCOME | ||||||
| Net Income | $-570.3M | $-408.2M | $-846.4M | $-738.8M | ||
| Net Income (Continuing Operations) | $-570.3M | $-408.2M | $-846.4M | $-738.8M | ||
| Net Income (Discontinued Operations) | $-570.3M | $-408.2M | $-846.4M | $-738.8M | ||
| Net Income (Common Stockholders) | $-570.3M | $-408.2M | $-846.4M | $-738.8M | ||
| Normalized Income | -- | -- | -- | $-730.0M | ||
| TOTALS | ||||||
| Total Expenses | $567.9M | $436.1M | $885.1M | $745.4M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $44.7M | $71.2M | $91.2M | $107.6M | ||
| Average Shares Outstanding (Diluted) | $44.7M | $71.2M | $91.2M | $107.6M | ||
| Shares Outstanding | $68.2M | $81.6M | $102.1M | $150.4M | ||
| Basic EPS | $-12.75 | $-5.73 | $-9.28 | $-6.86 | ||
| Basic EPS (Continuing Operations) | $-12.75 | $-5.73 | $-9.28 | $-6.86 | ||
| Diluted EPS | $-12.75 | $-5.73 | $-9.28 | $-6.86 | ||
| Diluted EPS (Continuing Operations) | $-12.75 | $-5.73 | $-9.28 | $-6.86 | ||
| OTHER METRICS | ||||||
| Other Gand A | $130.9M | $62.8M | $89.2M | $110.3M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BHVN | $10.07 | +6.6% | 2.22M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |